← FDA DRUG APPROVALS

FDA ANDA · ANDA075656

MORPHINE SULFATE

Sponsor: WATSON LABS

APPLICATION
ANDA075656
TYPE
ANDA
ORIGINAL APPROVAL
2001-01-30
LATEST ACTION
2015-01-15
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

MORPHINE SULFATEDiscontinued
MORPHINE SULFATE 100MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2015-01-15Labeling · Supplement 7 · standardAP
2003-10-10Labeling · Supplement 4AP
2002-07-15Manufacturing (CMC) · Supplement 3AP
2002-05-08Manufacturing (CMC) · Supplement 2AP
2002-03-27Manufacturing (CMC) · Supplement 1AP
2001-01-30OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →